Michael Somero Md Inc is categorized under Infectious Disease Specialists in Palm Desert, CA and active since 2000.
Michael Somero Md Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael Somero at the company’s single location by writing to 1401 North Palm Canyon Drive # 100, Palm Desert, California CA 92211 or by phoning (760) 346-8585. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Michael Somero Md Inc |
Contact Person: | Michael Somero |
Address: | 1401 North Palm Canyon Drive # 100, Palm Desert, California 92211 |
Phone Number: | (760) 346-8585 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Infectious Disease Specialists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Michael Somero Md Inc was started in 2000 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Somero for inquiries that concern Michael Somero Md Inc by calling the company number (760) 346-8585, as your correspondence is most welcome. Additionally, the physical location of the single location of Michael Somero Md Inc can be found at the coordinates as well as the street address 1401 North Palm Canyon Drive # 100 in Palm Desert, California 92211.
For its online presence, you may visit Michael Somero Md Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.